← Latest papers
📄 medicine

Functional Agent-Driven Computational Anatomy for Preoperative Siewert Classification of Adenocarcinoma of the Esophagogastric Junction Using Three-Dimensional Contrast- Enhanced CT: a retrospective multicenter diagnostic accuracy study

This retrospective multicenter study demonstrates that FACET, a functional agent-driven computational anatomy framework, improves the reproducibility and accuracy of preoperative Siewert classification for esophagogastric junction adenocarcinoma by converting subjective imaging assessments into calibrated, traceable 3D distance measurements on contrast-enhanced CT.

Original authors: Yiting Liu, Zifan Chen, Ruojin Li, Shuangxi Li, Li Zhang, Xiaoting Li, Yinkui Wang, Kan Xue, Fei Shan, Lei Tang, Ziyu Li

Published 2026-10-14
📖 5 min read🧠 Deep dive

Original authors: Yiting Liu, Zifan Chen, Ruojin Li, Shuangxi Li, Li Zhang, Xiaoting Li, Yinkui Wang, Kan Xue, Fei Shan, Lei Tang, Ziyu Li

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

In the complex landscape of human anatomy, few boundaries are as critical to surgical planning as the junction where the food pipe meets the stomach. This is the esophagogastric junction, a narrow passageway where a specific type of cancer, known as adenocarcinoma, frequently takes hold. For surgeons, the most vital question before an operation is not just whether the cancer is present, but exactly where its center lies in relation to this junction. This spatial relationship determines the entire surgical strategy: whether to remove more of the esophagus, how much of the stomach to take, and which lymph nodes to clear. Currently, doctors rely on a system called the Siewert classification to make this determination. It is a rule-based system that categorizes tumors into three types based on their distance from the junction. However, measuring this distance on standard medical scans has long been a subjective art. Radiologists look at two-dimensional slices of the body and estimate where the tumor starts and ends, a process that varies from person to person and often leads to inconsistent results, especially when tumors are large, irregular, or hidden behind other structures.

To solve this problem of human inconsistency, a team of researchers from Peking University and other institutions has developed a new digital tool called FACET. Rather than asking a computer to simply guess a tumor type, the researchers built a system that mimics the careful, step-by-step reasoning a surgeon uses. They treated the classification task not as a black-box prediction, but as a measurable geometry problem. The system takes a three-dimensional CT scan of a patient's chest and abdomen and automatically identifies the tumor and the surrounding anatomy. It then constructs a virtual path along the inner surface of the stomach and esophagus, tracing the exact route the tumor follows. By measuring the distance along this curved path from the center of the tumor to the junction, the software converts a vague visual estimate into a precise, reproducible number. This approach removes the guesswork, turning a subjective judgment into a traceable measurement that any doctor can verify.

The researchers tested this system on a large group of patients from multiple hospitals to see if it could match the accuracy of the gold standard: the physical examination of the tumor after it has been surgically removed. They divided their work into three stages. First, they taught the system using data from 70 patients. Next, they tested it on a separate group of 61 patients from the same hospital to ensure it wasn't just memorizing the first set of data. Finally, they challenged it with a completely new group of 45 patients from a different hospital to see if it would hold up in a real-world, independent setting. The results showed that the system worked well, correctly identifying the tumor type in about 73% of the cases in the final, independent group. While this is not a perfect score, it represents a significant step forward in consistency, particularly because the system achieved an area under the curve—a statistical measure of overall performance—of 0.770 in this external group, suggesting it can reliably distinguish between the different tumor types.

What makes this work distinct is how it handles the physical reality of the body. The researchers recognized that a tumor does not sit in a straight line; it follows the curves of the digestive tract. A simple straight-line measurement would be misleading. Instead, the software builds a map of the tumor's surface and calculates the distance along that surface, much like measuring the length of a winding road rather than the distance between two points on a map. To bridge the gap between the living body seen on a scan and the fixed tissue seen under a microscope after surgery, the team applied a specific calibration factor. This adjustment accounts for the fact that tissues shrink and change shape once they are removed from the body. By locking this factor at a specific value, the system ensures that the measurements taken from the scan align as closely as possible with the final pathological diagnosis.

The study also highlights the limitations of current medical imaging and the challenges that remain. The system was designed for patients who had not received prior chemotherapy or radiation, as those treatments can shrink tumors and distort the anatomy, making the measurements unreliable. Furthermore, the researchers noted that while the system is highly accurate for many cases, it still requires a human doctor to review the results, especially when the tumor boundaries are unclear or the anatomy is unusual. The tool is not a replacement for a surgeon's expertise but a powerful assistant that provides a clear, objective starting point. By making the invisible geometry of the tumor visible and measurable, this framework offers a new way to standardize preoperative planning, potentially leading to more consistent surgical outcomes and better care for patients facing this difficult disease.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →